Global Gabapentin Market Insights, Forecast to 2029

Global Gabapentin Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Gabapentin Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Gabapentin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gabapentin Sales Estimates and Forecasts 2018-2029
2.2 Global Gabapentin Revenue by Region
2.2.1 Global Gabapentin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Gabapentin Revenue by Region (2018-2023)
2.2.3 Global Gabapentin Revenue by Region (2024-2029)
2.2.4 Global Gabapentin Revenue Market Share by Region (2018-2029)
2.3 Global Gabapentin Sales Estimates and Forecasts 2018-2029
2.4 Global Gabapentin Sales by Region
2.4.1 Global Gabapentin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Gabapentin Sales by Region (2018-2023)
2.4.3 Global Gabapentin Sales by Region (2024-2029)
2.4.4 Global Gabapentin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Gabapentin Sales by Manufacturers
3.1.1 Global Gabapentin Sales by Manufacturers (2018-2023)
3.1.2 Global Gabapentin Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gabapentin in 2022
3.2 Global Gabapentin Revenue by Manufacturers
3.2.1 Global Gabapentin Revenue by Manufacturers (2018-2023)
3.2.2 Global Gabapentin Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Revenue in 2022
3.3 Global Key Players of Gabapentin, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Gabapentin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gabapentin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gabapentin, Product Offered and Application
3.8 Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gabapentin Sales by Type
4.1.1 Global Gabapentin Historical Sales by Type (2018-2023)
4.1.2 Global Gabapentin Forecasted Sales by Type (2024-2029)
4.1.3 Global Gabapentin Sales Market Share by Type (2018-2029)
4.2 Global Gabapentin Revenue by Type
4.2.1 Global Gabapentin Historical Revenue by Type (2018-2023)
4.2.2 Global Gabapentin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Gabapentin Revenue Market Share by Type (2018-2029)
4.3 Global Gabapentin Price by Type
4.3.1 Global Gabapentin Price by Type (2018-2023)
4.3.2 Global Gabapentin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Gabapentin Sales by Application
5.1.1 Global Gabapentin Historical Sales by Application (2018-2023)
5.1.2 Global Gabapentin Forecasted Sales by Application (2024-2029)
5.1.3 Global Gabapentin Sales Market Share by Application (2018-2029)
5.2 Global Gabapentin Revenue by Application
5.2.1 Global Gabapentin Historical Revenue by Application (2018-2023)
5.2.2 Global Gabapentin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Gabapentin Revenue Market Share by Application (2018-2029)
5.3 Global Gabapentin Price by Application
5.3.1 Global Gabapentin Price by Application (2018-2023)
5.3.2 Global Gabapentin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Gabapentin Market Size by Type
6.1.1 US & Canada Gabapentin Sales by Type (2018-2029)
6.1.2 US & Canada Gabapentin Revenue by Type (2018-2029)
6.2 US & Canada Gabapentin Market Size by Application
6.2.1 US & Canada Gabapentin Sales by Application (2018-2029)
6.2.2 US & Canada Gabapentin Revenue by Application (2018-2029)
6.3 US & Canada Gabapentin Market Size by Country
6.3.1 US & Canada Gabapentin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Gabapentin Sales by Country (2018-2029)
6.3.3 US & Canada Gabapentin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Gabapentin Market Size by Type
7.1.1 Europe Gabapentin Sales by Type (2018-2029)
7.1.2 Europe Gabapentin Revenue by Type (2018-2029)
7.2 Europe Gabapentin Market Size by Application
7.2.1 Europe Gabapentin Sales by Application (2018-2029)
7.2.2 Europe Gabapentin Revenue by Application (2018-2029)
7.3 Europe Gabapentin Market Size by Country
7.3.1 Europe Gabapentin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Gabapentin Sales by Country (2018-2029)
7.3.3 Europe Gabapentin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Gabapentin Market Size
8.1.1 China Gabapentin Sales (2018-2029)
8.1.2 China Gabapentin Revenue (2018-2029)
8.2 China Gabapentin Market Size by Application
8.2.1 China Gabapentin Sales by Application (2018-2029)
8.2.2 China Gabapentin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gabapentin Market Size by Type
9.1.1 Asia Gabapentin Sales by Type (2018-2029)
9.1.2 Asia Gabapentin Revenue by Type (2018-2029)
9.2 Asia Gabapentin Market Size by Application
9.2.1 Asia Gabapentin Sales by Application (2018-2029)
9.2.2 Asia Gabapentin Revenue by Application (2018-2029)
9.3 Asia Gabapentin Sales by Region
9.3.1 Asia Gabapentin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Gabapentin Revenue by Region (2018-2029)
9.3.3 Asia Gabapentin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gabapentin Market Size by Type
10.1.1 Middle East, Africa and Latin America Gabapentin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Gabapentin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gabapentin Market Size by Application
10.2.1 Middle East, Africa and Latin America Gabapentin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Gabapentin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gabapentin Sales by Country
10.3.1 Middle East, Africa and Latin America Gabapentin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Gabapentin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Gabapentin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Assertio Therapeutics
11.2.1 Assertio Therapeutics Company Information
11.2.2 Assertio Therapeutics Overview
11.2.3 Assertio Therapeutics Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Assertio Therapeutics Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Assertio Therapeutics Recent Developments
11.3 TEVA
11.3.1 TEVA Company Information
11.3.2 TEVA Overview
11.3.3 TEVA Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 TEVA Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TEVA Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Mylan Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Arbor Pharma
11.5.1 Arbor Pharma Company Information
11.5.2 Arbor Pharma Overview
11.5.3 Arbor Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Arbor Pharma Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Arbor Pharma Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Novartis Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Apotex
11.7.1 Apotex Company Information
11.7.2 Apotex Overview
11.7.3 Apotex Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Apotex Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Apotex Recent Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Information
11.8.2 Sun Pharmaceutical Overview
11.8.3 Sun Pharmaceutical Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sun Pharmaceutical Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sun Pharmaceutical Recent Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Information
11.9.2 Aurobindo Pharma Overview
11.9.3 Aurobindo Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Aurobindo Pharma Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aurobindo Pharma Recent Developments
11.10 Intas
11.10.1 Intas Company Information
11.10.2 Intas Overview
11.10.3 Intas Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Intas Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Intas Recent Developments
11.11 Amneal
11.11.1 Amneal Company Information
11.11.2 Amneal Overview
11.11.3 Amneal Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Amneal Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Amneal Recent Developments
11.12 Marksans Pharma
11.12.1 Marksans Pharma Company Information
11.12.2 Marksans Pharma Overview
11.12.3 Marksans Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Marksans Pharma Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Marksans Pharma Recent Developments
11.13 Glenmark
11.13.1 Glenmark Company Information
11.13.2 Glenmark Overview
11.13.3 Glenmark Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Glenmark Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Glenmark Recent Developments
11.14 Alkem
11.14.1 Alkem Company Information
11.14.2 Alkem Overview
11.14.3 Alkem Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Alkem Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Alkem Recent Developments
11.15 Jiangsu Enhua
11.15.1 Jiangsu Enhua Company Information
11.15.2 Jiangsu Enhua Overview
11.15.3 Jiangsu Enhua Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Jiangsu Enhua Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jiangsu Enhua Recent Developments
11.16 Jiangsu Hengrui
11.16.1 Jiangsu Hengrui Company Information
11.16.2 Jiangsu Hengrui Overview
11.16.3 Jiangsu Hengrui Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Jiangsu Hengrui Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Jiangsu Hengrui Recent Developments
11.17 Sailike
11.17.1 Sailike Company Information
11.17.2 Sailike Overview
11.17.3 Sailike Gabapentin Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Sailike Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sailike Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gabapentin Industry Chain Analysis
12.2 Gabapentin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gabapentin Production Mode & Process
12.4 Gabapentin Sales and Marketing
12.4.1 Gabapentin Sales Channels
12.4.2 Gabapentin Distributors
12.5 Gabapentin Customers
13 Market Dynamics
13.1 Gabapentin Industry Trends
13.2 Gabapentin Market Drivers
13.3 Gabapentin Market Challenges
13.4 Gabapentin Market Restraints
14 Key Findings in The Global Gabapentin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Gabapentin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Gabapentin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Gabapentin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Gabapentin Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Gabapentin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Gabapentin Revenue Market Share by Region (2018-2023)
Table 9. Global Gabapentin Revenue Market Share by Region (2024-2029)
Table 10. Global Gabapentin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Gabapentin Sales by Region (2018-2023) & (M Unit)
Table 12. Global Gabapentin Sales by Region (2024-2029) & (M Unit)
Table 13. Global Gabapentin Sales Market Share by Region (2018-2023)
Table 14. Global Gabapentin Sales Market Share by Region (2024-2029)
Table 15. Global Gabapentin Sales by Manufacturers (2018-2023) & (M Unit)
Table 16. Global Gabapentin Sales Share by Manufacturers (2018-2023)
Table 17. Global Gabapentin Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Gabapentin Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Gabapentin, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Gabapentin Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2022)
Table 23. Global Key Manufacturers of Gabapentin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Gabapentin, Product Offered and Application
Table 25. Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gabapentin Sales by Type (2018-2023) & (M Unit)
Table 28. Global Gabapentin Sales by Type (2024-2029) & (M Unit)
Table 29. Global Gabapentin Sales Share by Type (2018-2023)
Table 30. Global Gabapentin Sales Share by Type (2024-2029)
Table 31. Global Gabapentin Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Gabapentin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Gabapentin Revenue Share by Type (2018-2023)
Table 34. Global Gabapentin Revenue Share by Type (2024-2029)
Table 35. Gabapentin Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Gabapentin Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Gabapentin Sales by Application (2018-2023) & (M Unit)
Table 38. Global Gabapentin Sales by Application (2024-2029) & (M Unit)
Table 39. Global Gabapentin Sales Share by Application (2018-2023)
Table 40. Global Gabapentin Sales Share by Application (2024-2029)
Table 41. Global Gabapentin Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Gabapentin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Gabapentin Revenue Share by Application (2018-2023)
Table 44. Global Gabapentin Revenue Share by Application (2024-2029)
Table 45. Gabapentin Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Gabapentin Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Gabapentin Sales by Type (2018-2023) & (M Unit)
Table 48. US & Canada Gabapentin Sales by Type (2024-2029) & (M Unit)
Table 49. US & Canada Gabapentin Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Gabapentin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Gabapentin Sales by Application (2018-2023) & (M Unit)
Table 52. US & Canada Gabapentin Sales by Application (2024-2029) & (M Unit)
Table 53. US & Canada Gabapentin Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Gabapentin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Gabapentin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Gabapentin Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Gabapentin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Gabapentin Sales by Country (2018-2023) & (M Unit)
Table 59. US & Canada Gabapentin Sales by Country (2024-2029) & (M Unit)
Table 60. Europe Gabapentin Sales by Type (2018-2023) & (M Unit)
Table 61. Europe Gabapentin Sales by Type (2024-2029) & (M Unit)
Table 62. Europe Gabapentin Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Gabapentin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Gabapentin Sales by Application (2018-2023) & (M Unit)
Table 65. Europe Gabapentin Sales by Application (2024-2029) & (M Unit)
Table 66. Europe Gabapentin Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Gabapentin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Gabapentin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Gabapentin Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Gabapentin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Gabapentin Sales by Country (2018-2023) & (M Unit)
Table 72. Europe Gabapentin Sales by Country (2024-2029) & (M Unit)
Table 73. China Gabapentin Sales by Type (2018-2023) & (M Unit)
Table 74. China Gabapentin Sales by Type (2024-2029) & (M Unit)
Table 75. China Gabapentin Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Gabapentin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Gabapentin Sales by Application (2018-2023) & (M Unit)
Table 78. China Gabapentin Sales by Application (2024-2029) & (M Unit)
Table 79. China Gabapentin Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Gabapentin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Gabapentin Sales by Type (2018-2023) & (M Unit)
Table 82. Asia Gabapentin Sales by Type (2024-2029) & (M Unit)
Table 83. Asia Gabapentin Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Gabapentin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Gabapentin Sales by Application (2018-2023) & (M Unit)
Table 86. Asia Gabapentin Sales by Application (2024-2029) & (M Unit)
Table 87. Asia Gabapentin Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Gabapentin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Gabapentin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Gabapentin Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Gabapentin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Gabapentin Sales by Region (2018-2023) & (M Unit)
Table 93. Asia Gabapentin Sales by Region (2024-2029) & (M Unit)
Table 94. Middle East, Africa and Latin America Gabapentin Sales by Type (2018-2023) & (M Unit)
Table 95. Middle East, Africa and Latin America Gabapentin Sales by Type (2024-2029) & (M Unit)
Table 96. Middle East, Africa and Latin America Gabapentin Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Gabapentin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Gabapentin Sales by Application (2018-2023) & (M Unit)
Table 99. Middle East, Africa and Latin America Gabapentin Sales by Application (2024-2029) & (M Unit)
Table 100. Middle East, Africa and Latin America Gabapentin Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Gabapentin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Gabapentin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Gabapentin Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gabapentin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Gabapentin Sales by Country (2018-2023) & (M Unit)
Table 106. Middle East, Africa and Latin America Gabapentin Sales by Country (2024-2029) & (M Unit)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Pfizer Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Assertio Therapeutics Company Information
Table 113. Assertio Therapeutics Description and Major Businesses
Table 114. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Assertio Therapeutics Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Assertio Therapeutics Recent Developments
Table 117. TEVA Company Information
Table 118. TEVA Description and Major Businesses
Table 119. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. TEVA Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. TEVA Recent Developments
Table 122. Mylan Company Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Mylan Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Arbor Pharma Company Information
Table 128. Arbor Pharma Description and Major Businesses
Table 129. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Arbor Pharma Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Arbor Pharma Recent Developments
Table 132. Novartis Company Information
Table 133. Novartis Description and Major Businesses
Table 134. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Novartis Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Novartis Recent Developments
Table 137. Apotex Company Information
Table 138. Apotex Description and Major Businesses
Table 139. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Apotex Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Apotex Recent Developments
Table 142. Sun Pharmaceutical Company Information
Table 143. Sun Pharmaceutical Description and Major Businesses
Table 144. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Sun Pharmaceutical Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sun Pharmaceutical Recent Developments
Table 147. Aurobindo Pharma Company Information
Table 148. Aurobindo Pharma Description and Major Businesses
Table 149. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Aurobindo Pharma Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Aurobindo Pharma Recent Developments
Table 152. Intas Company Information
Table 153. Intas Description and Major Businesses
Table 154. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Intas Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Intas Recent Developments
Table 157. Amneal Company Information
Table 158. Amneal Description and Major Businesses
Table 159. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 160. Amneal Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Amneal Recent Developments
Table 162. Marksans Pharma Company Information
Table 163. Marksans Pharma Description and Major Businesses
Table 164. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 165. Marksans Pharma Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Marksans Pharma Recent Developments
Table 167. Glenmark Company Information
Table 168. Glenmark Description and Major Businesses
Table 169. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 170. Glenmark Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Glenmark Recent Developments
Table 172. Alkem Company Information
Table 173. Alkem Description and Major Businesses
Table 174. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 175. Alkem Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Alkem Recent Developments
Table 177. Jiangsu Enhua Company Information
Table 178. Jiangsu Enhua Description and Major Businesses
Table 179. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 180. Jiangsu Enhua Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Jiangsu Enhua Recent Developments
Table 182. Jiangsu Hengrui Company Information
Table 183. Jiangsu Hengrui Description and Major Businesses
Table 184. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 185. Jiangsu Hengrui Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Jiangsu Hengrui Recent Developments
Table 187. Sailike Company Information
Table 188. Sailike Description and Major Businesses
Table 189. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 190. Sailike Gabapentin Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Sailike Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Gabapentin Distributors List
Table 195. Gabapentin Customers List
Table 196. Gabapentin Market Trends
Table 197. Gabapentin Market Drivers
Table 198. Gabapentin Market Challenges
Table 199. Gabapentin Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Product Picture
Figure 2. Global Gabapentin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gabapentin Market Share by Type in 2022 & 2029
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Gabapentin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Gabapentin Market Share by Application in 2022 & 2029
Figure 8. Epilepsy
Figure 9. Neuropathic Pain
Figure 10. Restless Legs Syndrome
Figure 11. Others
Figure 12. Gabapentin Report Years Considered
Figure 13. Global Gabapentin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gabapentin Revenue 2018-2029 (US$ Million)
Figure 15. Global Gabapentin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Gabapentin Revenue Market Share by Region (2018-2029)
Figure 17. Global Gabapentin Sales 2018-2029 ((M Unit)
Figure 18. Global Gabapentin Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Gabapentin Sales YoY (2018-2029) & (M Unit)
Figure 20. US & Canada Gabapentin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Gabapentin Sales YoY (2018-2029) & (M Unit)
Figure 22. Europe Gabapentin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Gabapentin Sales YoY (2018-2029) & (M Unit)
Figure 24. China Gabapentin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Gabapentin Sales YoY (2018-2029) & (M Unit)
Figure 26. Asia (excluding China) Gabapentin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Gabapentin Sales YoY (2018-2029) & (M Unit)
Figure 28. Middle East, Africa and Latin America Gabapentin Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Gabapentin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Gabapentin in the World: Market Share by Gabapentin Revenue in 2022
Figure 31. Global Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Gabapentin Sales Market Share by Type (2018-2029)
Figure 33. Global Gabapentin Revenue Market Share by Type (2018-2029)
Figure 34. Global Gabapentin Sales Market Share by Application (2018-2029)
Figure 35. G

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......

Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110

Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......

Global Epilepsy Therapeutics Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......

Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......

Global Autism Spectrum Disorder Market Status and Outlook 2023-2028

Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109

Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......

Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......

Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98

Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......

2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel

Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89

This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......

Global Gabapentin Market Insights, Forecast to 2029

Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs